-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Bionik Laboratories Corp. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2014 to Q1 2023.
- Bionik Laboratories Corp. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending March 31, 2023 was 6.9M shares, a 18.1% increase year-over-year.
- Bionik Laboratories Corp. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 6.9M shares, a 18.1% increase from 2021.
- Bionik Laboratories Corp. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 5.84M shares, a 14% increase from 2020.
- Bionik Laboratories Corp. annual Weighted Average Number of Shares Outstanding, Diluted for 2020 was 5.13M shares.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)